Intel has made it clear that its expansion plans in the US partially hinge on government subsidies. Speaking live with the
Washington Post earlier this week, Intel CEO Pat Gelsinger made it clear that if the US Innovation and Competition Act (or USICA) isn't approved on the floor of Congress, the company will be seeking greener pastures across the Atlantic - namely in Europe, where the EU has been aggressively moving to increase local leading-edge chip manufacturing.
"We've made super clear to McConnell, to the Democrats, to the Republicans, that if this doesn't pass, I will change my plans," Gelsinger said. "The Europeans have moved forward very aggressively, and they're ready to give us the incentives that allow us to move forward," he said, likely referring to the
Silicon Junction initiative, which saw the EU open up its strings to a cool $43 billion in support for local manufacturing capabilities.
The measure is currently languishing on the Congress floor due to differences in opinion between Republicans and Democrats. The USICA bill would allocate up to $52 billion in incentives for semiconductor initiatives on US soil, and saw the creation of the
Semiconductors in America Coalition (SIAC) lobbying group.
The point of contention mostly lies in that Democrats could attempt to approve it as part of a broader reconciliation package that would allow Medicare to negotiate prices with drug manufacturers, which would help control prescription drug prices while putting a cap on insulin prices {..snip..}